TANOVEA® (rabacfosadine for injection) Receives Full FDA Approval as First Treatment for Lymphoma in Dogs; Elanco Acquires Product from VetDC, Inc

Elanco Animal Health Incorporated (NYSE: ELAN) announced that the  FDA has granted full approval of Tanovea for the treatment of lymphoma in dogs, making this the first conditionally approved new...

Learn More

FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

Today, the U.S. Food and Drug Administration fully approved Tanovea (rabacfosadine injection) to treat lymphoma in dogs. Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many s...

Learn More

Long-time CBSA Member Aerotek to Change Name

Aerotek, a leading talent solutions provider, today revealed that its three highly specialized business units—Industrial, Professional, and Engineering and Sciences—have separated into independen...

Learn More

ARCA Biopharma Provides Update On Aspen-COVID-19 Phase 2B Clinical Trial Evaluating RNAPC2 as a Potential Treatment for COVID-19

CBSA Member ARCA Biopharama is receiving approvals from regulators in Argentina and Brazil to test your possible COVID-19 treatment. Find out more in the press release.

Learn More

VitriVax Announces Series A Financing to Further Demonstrate Feasibility of its Thermostable, Single-Dose Vaccine Technology, Aiming to Make Life-Saving Biologics Widely Accessible to Underserved Populations Globally

VitriVax, developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. Series A...

Learn More

DOD, HHS Awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19

On July 8, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $35.1 million contract to LightDeck Diagnostic...

Learn More

PharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Control...

Learn More

AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings

AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy...

Learn More

Vaporox Closes on a $4M Series A Fund Raising Round Led by Bioventus

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative...

Learn More

At-home fertility test kit maker Proov expands to EU after landing CE clearance

At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit. Proov’s ovulation testing kit got clearance by the F...

Learn More